A detailed history of Federated Hermes, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 658,130 shares of PRCT stock, worth $41.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
658,130
Previous 506,226 30.01%
Holding current value
$41.7 Million
Previous $40.6 Million 30.67%
% of portfolio
0.12%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$67.27 - $99.45 $10.2 Million - $15.1 Million
151,904 Added 30.01%
658,130 $53 Million
Q3 2024

Nov 13, 2024

BUY
$56.31 - $84.99 $18.2 Million - $27.4 Million
322,806 Added 175.99%
506,226 $40.6 Million
Q2 2024

Aug 08, 2024

BUY
$45.73 - $69.19 $7.44 Million - $11.3 Million
162,785 Added 788.88%
183,420 $11.2 Million
Q1 2024

May 14, 2024

BUY
$40.38 - $50.75 $833,241 - $1.05 Million
20,635 New
20,635 $1.02 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.83B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.